Skip to results

Last updated date

Last updated date

Type

Type

Guidance programme

Advice programme

Showing 1 to 20 of 20

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Belimumab for treating active autoantibody-positive systemic lupus erythematosusTA752
Brain tumours (primary) and brain metastases in over 16sQS203
Cenobamate for treating focal onset seizures in epilepsyTA753
ClearGuard HD antimicrobial barrier caps for preventing haemodialysis catheter-related bloodstream infectionsMTG62
Colorectal cancerNG151
Dupilumab for treating severe asthma with type 2 inflammationTA751
Endo-SPONGE for treating low rectal anastomotic leakMTG63
Endobronchial nerve ablation for chronic obstructive pulmonary diseaseIPG714
Fedratinib for treating disease-related splenomegaly or symptoms in myelofibrosisTA756
FreeO2 automatic oxygen titration for chronic obstructive pulmonary disease and respiratory distress syndromeMIB281
Headaches in over 12s: diagnosis and managementCG150
Liraglutide for managing obesity in people aged 12 to 17 years (terminated appraisal)TA749
Mexiletine for treating the symptoms of myotonia in non-dystrophic myotonic disordersTA748
Mogamulizumab for previously treated mycosis fungoides and Sézary syndromeTA754
Olaparib for maintenance treatment of BRCA mutation-positive metastatic pancreatic cancer after platinum-based chemotherapy (terminated appraisal)TA750
Pelvic floor dysfunction: prevention and non-surgical managementNG210
Prostate cancerQS91
Prostate cancer: diagnosis and managementNG131
Transanal total mesorectal excision for rectal cancerIPG713
Urinary incontinence in womenQS77

Results per page

  1. 10
  2. 25
  3. 50
  4. All